interest and
we can share
more detail
and/or arrange
time.

e Skin
microbiom
e: NIAID
researche
rs
developed
a topical
therapy

for
eczema
that
involves
treating
skin with
“good”
bacteria.
If proven
effective
, this
strategy
could
offer an
inexpensil
ve
treatment
that
requires
less
frequent
applicati
on than
many
current
eczema
medicatio
ns. A
Phase 1/2
trial at
NIH
indicated

NIH-001400
